“In some patients, noticeably those with thalassemia major, sickle cell disease,myelodysplastic syndrome, aplastic anemia, hemolytic anemia, and refractory sideroblastic anemias, who may become transfusion-dependent and receive excess iron with each transfusion (that the body has no means to excrete), iron gradually accumulates in various tissues, causing morbidity and mortality.”
- In Stark Contrast To ACA Plans, Premiums For Job-Based Coverage Show Modest Rise September 19, 2017Employers report the sixth consecutive year of small increases, but workers at small firms feel the biggest pinch, according to the Kaiser Family Foundation survey.Phil Galewitz, Kaiser Health News
- Nursing Home Disaster Plans Often Faulted As ‘Paper Tigers’ September 19, 2017Too often enforcement of rules for dealing with crisis is lax, advocates for nursing home residents say.Jordan Rau, Kaiser Health News
- As Care Shifts From Hospital To Home, Guarding Against Infection Falls To Families September 19, 2017Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.Melissa Bailey, Kaiser Health News
- In Stark Contrast To ACA Plans, Premiums For Job-Based Coverage Show Modest Rise September 19, 2017
Our MissionThe mission of the Hemochromatosis Information Society is to promote public awareness about the genetic disorder hereditary hemochromatosis. The organization strives to meet the needs of those individuals, their families and friends diagnosed with hereditary hemochromatosis. In order to prevent adverse health effects and premature death, the Hemochromatosis Information Society supports routine screening of patients for hereditary hemochromatosis.
Message from the PresidentThe goal of the Hemochromatosis Information Society web site is to provide valuable information for people with hereditary hemochromatosis. We want to be your online resource for hemochromatosis information. We strive to provide accurate, timely information regarding hemochromatosis and its treatment.